InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.68
(
0.24%
)
Bitcoin
63,231.78
(
0.10%
)

Replies to post #5393 on Synaptogenix Inc (SNPX)

Replies to #5393 on Synaptogenix Inc (SNPX)

XenaLives

09/21/17 3:59 PM

#5394 RE: runncoach #5393

NTRP didn't do an adaptive trial, so are they going to start over with P1 in oral dosage?

Whatsupp

09/22/17 11:14 AM

#5399 RE: runncoach #5393



Coach - looks to me like some bio hopeful investors and companies that have not run any meaningful studies are waiting for the elimination of having to actually treat more than 50 patients before they get FDA approval.